Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Clinical trial NCT02055196 · WITHDRAWN

Trial details

NCT number: NCT02055196
Sponsor: City of Hope Medical Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Anaplastic Astrocytoma Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor

Primary completion: 2014-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.